Epigenetic Pathways and Glioblastoma Treatment: Insights from Signaling Cascades

Bryce K. Allen, Vasileios Stathias, Marie E. Maloof, Dusica Vidovic, Emily F. Winterbottom, Anthony J. Capobianco, Jennifer Clarke, Stephan Schurer, David J. Robbins, Nagi G. Ayad

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


There is an urgent need to identify novel therapies for glioblastoma (GBM) as most therapies are ineffective. A first step in this process is to identify and validate targets for therapeutic intervention. Epigenetic modulators have emerged as attractive drug targets in several cancers including GBM. These epigenetic regulators affect gene expression without changing the DNA sequence. Recent studies suggest that epigenetic regulators interact with drivers of GBM cell and stem-like cell proliferation. These drivers include components of the Notch, Hedgehog, and Wingless (WNT) pathways. We highlight recent studies connecting epigenetic and signaling pathways in GBM. We also review systems and big data approaches for identifying patient specific therapies in GBM. Collectively, these studies will identify drug combinations that may be effective in GBM and other cancers. J. Cell. Biochem. 116: 351-363, 2015.

Original languageEnglish (US)
Pages (from-to)351-363
Number of pages13
JournalJournal of Cellular Biochemistry
Issue number3
StatePublished - Mar 1 2015



ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Epigenetic Pathways and Glioblastoma Treatment: Insights from Signaling Cascades'. Together they form a unique fingerprint.

Cite this